260 related articles for article (PubMed ID: 29651785)
1. Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques.
Delaney SR; Malik PRV; Stefan C; Edginton AN; Colantonio DA; Ito S
Clin Pharmacokinet; 2018 Dec; 57(12):1603-1611. PubMed ID: 29651785
[TBL] [Abstract][Full Text] [Related]
2. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.
Weisskopf E; Guidi M; Fischer CJ; Bickle Graz M; Beaufils E; Nguyen KA; Morisod Harari M; Rouiller S; Rothenburger S; Gaucherand P; Kassai-Koupai B; Borradori Tolsa C; Epiney M; Tolsa JF; Vial Y; Hascoët JM; Claris O; Eap CB; Panchaud A; Csajka C
Br J Clin Pharmacol; 2020 Aug; 86(8):1642-1653. PubMed ID: 32162723
[TBL] [Abstract][Full Text] [Related]
3. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
4. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.
Rampono J; Kristensen JH; Hackett LP; Paech M; Kohan R; Ilett KF
Br J Clin Pharmacol; 2000 Sep; 50(3):263-8. PubMed ID: 10971311
[TBL] [Abstract][Full Text] [Related]
5. Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions.
Yeung CHT; Autmizguine J; Dalvi P; Denoncourt A; Ito S; Katz P; Rahman M; Theoret Y; Edginton AN
Clin Pharmacokinet; 2024 Mar; 63(3):317-332. PubMed ID: 38278872
[TBL] [Abstract][Full Text] [Related]
6. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
Berle JØ; Steen VM; Aamo TO; Breilid H; Zahlsen K; Spigset O
J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050
[TBL] [Abstract][Full Text] [Related]
7. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
[TBL] [Abstract][Full Text] [Related]
8. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women.
Lobo ED; Loghin C; Knadler MP; Quinlan T; Zhang L; Chappell J; Lucas R; Bergstrom RF
Clin Pharmacokinet; 2008; 47(2):103-9. PubMed ID: 18193916
[TBL] [Abstract][Full Text] [Related]
10. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.
Rampono J; Hackett LP; Kristensen JH; Kohan R; Page-Sharp M; Ilett KF
Br J Clin Pharmacol; 2006 Sep; 62(3):316-22. PubMed ID: 16934048
[TBL] [Abstract][Full Text] [Related]
11. Citalopram in pregnancy and lactation.
Heikkinen T; Ekblad U; Kero P; Ekblad S; Laine K
Clin Pharmacol Ther; 2002 Aug; 72(2):184-91. PubMed ID: 12189365
[TBL] [Abstract][Full Text] [Related]
12. [The transfer of selective serotonin reuptake inhibitors to human milk].
Nordeng H; Bergsholm YK; Bøhler E; Spigset O
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment.
Canbolat F; Tasdemir Erinç DM; Evrensel A; Aydın A; Tarhan KN
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):285-297. PubMed ID: 30220109
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants in breast milk; comparative analysis of excretion ratios.
Schoretsanitis G; Augustin M; Saßmannshausen H; Franz C; Gründer G; Paulzen M
Arch Womens Ment Health; 2019 Jun; 22(3):383-390. PubMed ID: 30116895
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
Stowe ZN; Hostetter AL; Owens MJ; Ritchie JC; Sternberg K; Cohen LS; Nemeroff CB
J Clin Psychiatry; 2003 Jan; 64(1):73-80. PubMed ID: 12590627
[TBL] [Abstract][Full Text] [Related]
16. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
Epperson N; Czarkowski KA; Ward-O'Brien D; Weiss E; Gueorguieva R; Jatlow P; Anderson GM
Am J Psychiatry; 2001 Oct; 158(10):1631-7. PubMed ID: 11578995
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
[No Abstract] [Full Text] [Related]
18. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
Newport DJ; Ritchie JC; Knight BT; Glover BA; Zach EB; Stowe ZN
J Clin Psychiatry; 2009 Sep; 70(9):1304-10. PubMed ID: 19607765
[TBL] [Abstract][Full Text] [Related]
19. Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine.
Yeung CHT; Ito S; Autmizguine J; Edginton AN
AAPS J; 2021 May; 23(4):70. PubMed ID: 34002327
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability of two escitalopram formulations in healthy human volunteers.
Mendes GD; Babadopulos T; Bau FR; Chen LS; De Nucci G
Int J Clin Pharmacol Ther; 2010 Aug; 48(8):554-62. PubMed ID: 20650049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
